论文部分内容阅读
应用诺和锐30特充对临床49例继发失效患者实施强化治疗。结果:治疗后血糖、HbA1c较治疗前明显下降(P<0.01);INS明显提高(P<0.01);治疗前后空腹C肽无显著性差异,餐后1h、2h C肽有显著性差异。结论:诺和锐30特充治疗2型糖尿病继发性磺脲类药物失效,效果良好。
Application Novo Rui 30 special charge on the clinical 49 patients with secondary failure to implement intensive treatment. Results: After treatment, HbA1c level decreased significantly (P <0.01) and INS significantly increased (P <0.01). There was no significant difference in fasting C peptide between before and after treatment. There was a significant difference of C peptide between 1 hour and 2 hours after treatment. Conclusion: Nuohe Rui 30 superficial treatment of type 2 diabetes secondary sulfonylurea failure, the effect is good.